Table 3.

Incidence and severity of AOD in the ovarian grafts of NOv-d3tx B6AF1 mice that received 3 × 10⁵ Tregs

	AOD in ovarian graft		Dacryoadenitis
Treg donor	Incidence, % (n)	Severity*	Incidence, % (n)	Severity*
None	63 (11)	2.0 ± 0.2	72 (11)	1.5 ± 0.2
Female	8 (12)	1.5 ± 0	0 (12)	–
Male	63 (11)	1.9 ± 0.2	0 (11)	–

The female recipients were ovariectomized at the day of birth, thymectomized at day 3, received implants of an age-matched syngeneic ovary at week 3, and studied at week 7 to 8. They also received the Tregs at day 5.

^*Mean ± SD of mice with disease